The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Checkmate Pharmaceuticals, Inc(NASDAQ:CMPI)


Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanom...
Website: http://www.checkmatepharma.com
Founded: 2015
Full Time Employees: 25 (May 2021)
CEO: Barry A. Labinger
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Checkmate Pharmaceuticals Op Cashflow Per Share ttm
Checkmate Pharmaceuticals Free Cashflow Per Share ttm
Checkmate Pharmaceuticals Cash Per Share ttm
Checkmate Pharmaceuticals (GAAP) P/E ratio ttm
Checkmate Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.